Home | News | Directories | Calendar | Maps | Contact Us | Webmail
Perelman School of Medicine at the University of Pennsylvania Advanced Search

Janet L Kwiatkowski, MD, MSCE

Janet L Kwiatkowski, MD, MSCE

faculty photo
Associate Professor of Pediatrics at the Children's Hospital of Philadelphia
Department: Pediatrics

Contact information
The Children's Hospital of Philadelphia
Division of Hematology
3401 Civic Center Blvd
Colket Translational Research Building, Room 11024
Philadelphia, PA 19104
Office: 215-590-5286
Education:
B.S. (Zoology)
Duke University, summa cum laude, 1988.
M.D.
Columbia University, College of Physicians & Surgeons, 1992.
MSCE (Clinical Epidemiology and Biostatistics)
University of Pennsylvania, 2003.
Permanent link
 
Perelman School of Medicine > Faculty > Search

Description of Research Expertise

Optimization of iron chelation, monitoring transfusional iron overload, stroke prevention in sickle cell disease, headaches in sickle cell disease, complications of thalassemia, transfusion therapy

Description of Clinical Expertise

General pediatric hematology, thalassemia, sickle cell disease, transfusional iron overload, chelation therapy

Selected Publications

Belmont Ami, Kwiatkowski Janet L: Deferiprone for the treatment of transfusional iron overload in thalassemia. Expert review of hematology 10(6): 493-503, Jun 2017.

Lambert Michele P, Witmer Char M, Kwiatkowski Janet L: Therapy induced iron deficiency in children treated with eltrombopag for immune thrombocytopenia. American journal of hematology 92(6): E88-E91, Jun 2017.

Hamm J, Rathore N, Lee P, LeBlanc Z, Lebensburger J, Meier ER, Kwiatkowski, JL: Cranial Epidural Hematomas: A Case Series and Literature Review of This Rare Complication Associated with Sickle Cell Disease. Pediatric Blood & Cancer 64(3): e26237, March 2017.

Dowling MM, QuinnCT, Ramaciotti C, Kanter J, Osunkwo I, Inusa B, Iyer R, Kwiatkowski JL, Johnson C, Rhodes M, Owen W, Strouse JJ, Panepinto JA, Neumayr L, Sarnaik S, Plumb PA, Diamini N, Kirkham F, Hynan LS, PFAST Investigators: Increased prevalence of potential right-to-left shunting in children with sickle cell anaemia and stroke. British Journal of Haematology 176(2): 300-308, January 2017.

Adams RJ, Lackland DT, Brown L, Brown D, Voeks J, Fullerton HJ, Kanter J and Kwiatkowski JL: Transcranial Doppler Re-Screening of Subjects who Participated in STOP and STOP II. American Journal of Hematology 91(12): 1191-1194, December 2016.

Stanley Helen M, Friedman David F, Webb Jennifer, Kwiatkowski Janet L: Transfusional Iron Overload in a Cohort of Children with Sickle Cell Disease: Impact of Magnetic Resonance Imaging, Transfusion Method, and Chelation. Pediatric Blood & Cancer 63(8): 1414-8, Aug 2016.

Nabavizadeh S Ali, Vossough Arastoo, Ichord Rebecca N, Kwiatkowski Janet, Pukenas Bryan A, Smith Michelle J, Storm Philip B, Zager Eric L, Hurst Robert W: Intracranial aneurysms in sickle cell anemia: clinical and imaging findings. Journal of neurointerventional surgery 8(4): 434-40, Apr 2016.

Kwiatkowski Janet L: Current recommendations for chelation for transfusion-dependent thalassemia. Annals of the New York Academy of Sciences 1368(1): 107-14, Mar 2016.

Ware Russell E, Davis Barry R, Schultz William H, Brown R Clark, Aygun Banu, Sarnaik Sharada, Odame Isaac, Fuh Beng, George Alex, Owen William, Luchtman-Jones Lori, Rogers Zora R, Hilliard Lee, Gauger Cynthia, Piccone Connie, Lee Margaret T, Kwiatkowski Janet L, Jackson Sherron, Miller Scott T, Roberts Carla, Heeney Matthew M, Kalfa Theodosia A, Nelson Stephen, Imran Hamayun, Nottage Kerri, Alvarez Ofelia, Rhodes Melissa, Thompson Alexis A, Rothman Jennifer A, Helton Kathleen J, Roberts Donna, Coleman Jamie, Bonner Melanie J, Kutlar Abdullah, Patel Niren, Wood John, Piller Linda, Wei Peng, Luden Judy, Mortier Nicole A, Stuber Susan E, Luban Naomi L C, Cohen Alan R, Pressel Sara, Adams Robert J: Hydroxycarbamide versus chronic transfusion for maintenance of transcranial doppler flow velocities in children with sickle cell anaemia-TCD With Transfusions Changing to Hydroxyurea (TWiTCH): a multicentre, open-label, phase 3, non-inferiority trial. Lancet (London, England) 387(10019): 661-70, Feb 2016.

Luchtman-Jones Lori, Pressel Sara, Hilliard Lee, Brown R Clark, Smith Mary G, Thompson Alexis A, Lee Margaret T, Rothman Jennifer, Rogers Zora R, Owen William, Imran Hamayun, Thornburg Courtney, Kwiatkowski Janet L, Aygun Banu, Nelson Stephen, Roberts Carla, Gauger Cynthia, Piccone Connie, Kalfa Theodosia, Alvarez Ofelia, Hassell Kathryn, Davis Barry R, Ware Russell E: Effects of hydroxyurea treatment for patients with hemoglobin SC disease. American Journal of Hematology 91(2): 238-42, Feb 2016.

back to top
Last updated: 07/19/2017
The Trustees of the University of Pennsylvania